• Naturally Splendid (NSP) has settled a court action with former CEO, Douglas Mason
  • Mr. Mason sued the company in October 2019 for firing him and failing to pay his termination fee of C$90,000
  • The company has made a one-time payment to Mr. Mason of C$45,000
  • Shares in the Naturally Splendid are currently down 7.14 per cent to 6.5 cents, with a market cap of C$8.65 million

Hemp-based health food company, Naturally Splendid (NSP), has announced the settlement of a court action with former CEO, Douglas Mason.

Mr. Mason was originally appointed as CEO of the company in April 2018 but resigned, according to an announcement filed by Naturally Splendid, in August 2019.

However, Mr. Mason sued the company two months later, claiming that it had constructively fired him and failed to pay his termination fee of C$90,000 – the equivalent of six months’ pay.

Mr. Mason’s claim, which was filed on October 15, 2019, stated that his tenure came to an unexpected end despite performing his job in accordance with the necessary duties of a CEO.

The claim went on to explain that Naturally Splendid had failed to pay a C$15,000 per month fee to his privately held company, Waterfront Capital, for June, July and August of 2019; which ultimately contributed to his constructive dismissal.

In addition, Mr. Mason sought to recoup C$2,500 for his duties as a director, plus C$500 for each board meeting he attended.

Today’s announcement revealed that Naturally Splendid has settled the court action with Mr. Mason in a one-time payment of C$45,000.

Mr. Mason has subsequently provided a full and final release to the company.

It’s not the first time that Naturally Splendid has faced legal action. In 2018, the company was served a statement of claim by Terramax Holdings related to an alleged breach of agreement regarding the purported “cleaning” of hemp seeds.

Under the action, Terramax sought damages of C$3,000,000 plus interest and costs.

Shares in the company are currently down 7.14 per cent to 6.5 cents, with a market cap of C$8.65 million.

More From The Market Online

Tilray Brands seeks US$250M for U.S. cannabis expansion

Global cannabis stock Tilray Brands (TSX:TLRY) intends to raise up to US$250 million to fund its U.S. expansion plan.

The Market Online’s Weekly Cannabis Report – May 17, 2024

This international biopharmaceutical company revealed it has completed the retrospective observational real-world evidence study.

Avicanna finishes study of CBD cream’s use for rare skin disorder

Avicanna (TSX:AVCN) completes an observational study of its RHO Phyto-branded Ultra CBD topical cream on patients with epidermolysis bullosa.